SGMO Stock Analysis: Buy, Sell, or Hold?

SGMO - Sangamo Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$0.54
0.02 (4.39%) ▲
HOLD
MODERATE Confidence
Protect Your SGMO Gains
Last Updated: January 30, 2026
Earnings: Mar 16, 2026

Get Alerted When SGMO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD - EXTENDED: SGMO is 13.9% above fair value ($0.47). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.

In-depth Analysis How we analyze

Valuation Analysis: SGMO is currently trading at $0.54, which is considered extended relative to its 30-day fair value range of $0.39 to $0.47.

Technical Outlook: Technically, SGMO is in a strong downtrend. The price is approaching resistance at $0.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.4% recently.

Market Sentiment: SGMO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.81 (+643.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $0.39 - $0.47
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Protect Your Profits

Holding SGMO? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price significantly overextended (+13.9% above fair value)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.4%)
  • BULLISH: Trading 643.2% below Wall St target ($3.81)

Fair Price Analysis

30-Day Fair Range $0.39 - $0.47
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $0.36
Resistance Level $0.53
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -2.23
Wall Street Target $3.81 (+643.2%)
Revenue Growth (YoY) -98.8%
Last updated: January 31, 2026 4:07 AM ET
Data refreshes hourly during market hours. Next update: 5:07 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$404 63 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$64 55 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$8 53 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$102 62 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$85 55 HOLD

Advanced SGMO Option Strategies

Professional options setups generated by AI based on today's SGMO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for SGMO

SGMO Technical Chart SGMO Price Prediction SGMO Earnings Date SGMO Investment Advisor SGMO Fair Price Analyzer SGMO Options Advisor SGMO Options Chain SGMO Options Analysis SGMO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals